Unknown

Dataset Information

0

Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis.


ABSTRACT: Breast cancer frequently metastasizes to bone, where it leads to secondary tumor growth, osteolytic bone degradation, and poor clinical prognosis. Hydroxyapatite Ca(10)(PO(4))(6)(OH)(2) (HA), a mineral closely related to the inorganic component of bone, may be implicated in these processes. However, it is currently unclear how the nanoscale materials properties of bone mineral, such as particle size and crystallinity, which change as a result of osteolytic bone remodeling, affect metastatic breast cancer. We have developed a two-step hydrothermal synthesis method to obtain HA nanoparticles with narrow size distributions and varying crystallinity. These nanoparticles were incorporated into gas-foamed/particulate leached poly(lactide-co-glycolide) scaffolds, which were seeded with metastatic breast cancer cells to create mineral-containing scaffolds for the study of breast cancer bone metastasis. Our results suggest that smaller, poorly-crystalline HA nanoparticles promote greater adsorption of adhesive serum proteins and enhance breast tumor cell adhesion and growth relative to larger, more crystalline nanoparticles. Conversely, the larger, more crystalline HA nanoparticles stimulate enhanced expression of the osteolytic factor interleukin-8 (IL-8). Our data suggest an important role for nanoscale HA properties in the vicious cycle of bone metastasis and indicate that mineral-containing tumor models may be excellent tools to study cancer biology and to define design parameters for non-tumorigenic mineral-containing or mineralized matrices for bone regeneration.

SUBMITTER: Pathi SP 

PROVIDER: S-EPMC3613283 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis.

Pathi Siddharth P SP   Lin Debra D W DD   Dorvee Jason R JR   Estroff Lara A LA   Fischbach Claudia C  

Biomaterials 20110420 22


Breast cancer frequently metastasizes to bone, where it leads to secondary tumor growth, osteolytic bone degradation, and poor clinical prognosis. Hydroxyapatite Ca(10)(PO(4))(6)(OH)(2) (HA), a mineral closely related to the inorganic component of bone, may be implicated in these processes. However, it is currently unclear how the nanoscale materials properties of bone mineral, such as particle size and crystallinity, which change as a result of osteolytic bone remodeling, affect metastatic brea  ...[more]

Similar Datasets

| S-EPMC7284761 | biostudies-literature
| S-EPMC4356216 | biostudies-literature
| S-EPMC5995873 | biostudies-literature
| S-EPMC7563183 | biostudies-literature
| S-EPMC7597806 | biostudies-literature
| S-EPMC8164647 | biostudies-literature
| S-ECPF-GEOD-46214 | biostudies-other
| S-EPMC5299100 | biostudies-literature
| S-EPMC8588077 | biostudies-literature
| S-EPMC3405892 | biostudies-other